These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 27220334)
21. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology. Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772 [TBL] [Abstract][Full Text] [Related]
22. First-in-Rat Study of Human Alzheimer's Disease Tau Propagation. Smolek T; Jadhav S; Brezovakova V; Cubinkova V; Valachova B; Novak P; Zilka N Mol Neurobiol; 2019 Jan; 56(1):621-631. PubMed ID: 29770957 [TBL] [Abstract][Full Text] [Related]
23. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. Iba M; Guo JL; McBride JD; Zhang B; Trojanowski JQ; Lee VM J Neurosci; 2013 Jan; 33(3):1024-37. PubMed ID: 23325240 [TBL] [Abstract][Full Text] [Related]
24. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology. Hochgräfe K; Sydow A; Mandelkow EM FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246 [TBL] [Abstract][Full Text] [Related]
25. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. Castillo-Carranza DL; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Gerson JE; Singh G; Estes DM; Barrett AD; Dineley KT; Jackson GR; Kayed R J Neurosci; 2014 Mar; 34(12):4260-72. PubMed ID: 24647946 [TBL] [Abstract][Full Text] [Related]
26. Caspase activation precedes and leads to tangles. de Calignon A; Fox LM; Pitstick R; Carlson GA; Bacskai BJ; Spires-Jones TL; Hyman BT Nature; 2010 Apr; 464(7292):1201-4. PubMed ID: 20357768 [TBL] [Abstract][Full Text] [Related]
27. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study. Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899 [TBL] [Abstract][Full Text] [Related]
28. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease. Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679 [TBL] [Abstract][Full Text] [Related]
29. Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease. Jarero-Basulto JJ; Luna-Muñoz J; Mena R; Kristofikova Z; Ripova D; Perry G; Binder LI; Garcia-Sierra F J Neuropathol Exp Neurol; 2013 Dec; 72(12):1145-61. PubMed ID: 24226268 [TBL] [Abstract][Full Text] [Related]
30. Tau protein aggregation is associated with cellular senescence in the brain. Musi N; Valentine JM; Sickora KR; Baeuerle E; Thompson CS; Shen Q; Orr ME Aging Cell; 2018 Dec; 17(6):e12840. PubMed ID: 30126037 [TBL] [Abstract][Full Text] [Related]
31. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development. Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535 [TBL] [Abstract][Full Text] [Related]
32. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426 [TBL] [Abstract][Full Text] [Related]
33. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936 [TBL] [Abstract][Full Text] [Related]
34. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359 [TBL] [Abstract][Full Text] [Related]
35. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies. Xiang J; Wang ZH; Ahn EH; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Ju G; Wu S; Ye K Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9094-9102. PubMed ID: 31004063 [TBL] [Abstract][Full Text] [Related]
36. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties. Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846 [TBL] [Abstract][Full Text] [Related]
37. Distinct relationships of amyloid-beta and tau deposition to cerebral glucose metabolic networks in Alzheimer's disease. Sun X; Nie B; Zhao S; Ai L; Chen Q; Zhang T; Pan T; Wang L; Yin X; Zhang W; Shan B; Liu H; Liang S; Wang G Neurosci Lett; 2020 Jan; 717():134699. PubMed ID: 31874218 [TBL] [Abstract][Full Text] [Related]
38. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains. Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795 [TBL] [Abstract][Full Text] [Related]
39. SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer's Disease. Liu B; Liu J; Shi JS J Alzheimers Dis; 2020; 75(2):385-395. PubMed ID: 32310176 [TBL] [Abstract][Full Text] [Related]